Interstitial photodynamic therapy and glioblastoma: Light fractionation study on a preclinical model: Preliminary results

Progress in Biomedical Optics and Imaging - Proceedings of SPIE

Volumn 9305, Issue , 2015, Pages

  Leroy, Henri Arthur ^a,b,c   Vermandel, Maximilien ^a,b,c   Tétard, Marie Charlotte ^a,b,c   Lejeune, Jean Paul ^a,b,c   Mordon, Serge ^a   Reyns, Nicolas ^a,b,c  

^a INSERM   (France)

^b LILLE UNIVERSITY HOSPITAL   (France)

^c UNIV LILLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALS; DIFFUSION; HISTOLOGY; MAGNETIC RESONANCE IMAGING; NEUROSURGERY; PHOTOSENSITIZERS; RATS; TUMORS;

CYTOTOXIC SPECIES; HISTOLOGICAL DATA; LOCAL RECURRENCE; NEO-VASCULARIZATION; PHOTODYNAMIC THERAPY (PDT); TISSUE OXYGENATION; TREATMENT EFFECTS; TREATMENT EFFICIENCY;

PHOTODYNAMIC THERAPY;

EID: 84928128691     PISSN: 16057422     EISSN: None     Source Type: Conference Proceeding    
DOI: 10.1117/12.2079347     Document Type: Conference Paper

References (32)

1. Bechet D AF, Couleaud P, Marty E, Ravasi L, Durieux N, Bonnet C, Plénat F, Frochot C, Mordon S, Tillement O, Vanderesse R, Lux F, Perriat P, Guillemin, Barberi-Heyob M: Multifunctional ultrasmall nanoplatforms for vascular-targeted interstitial photodynamic therapy of brain tumors guided by real time MRI. Nanomedecine, 2014
2. Beck TJ, Kreth FW, Beyer W, Mehrkens JH, Obermeier A, Stepp H, et al: Interstitial photodynamic therapy of nonresectable malignant glioma recurrences using 5-aminolevulinic acid induced protoporphyrin IX. Lasers in surgery and medicine 39:386-393, 2007
3. Candolfi M, Curtin JF, Nichols WS, Muhammad AG, King GD, Pluhar GE, et al: Intracranial glioblastoma models in preclinical neuro-oncology: neuropathological characterization and tumor progression. Journal of neuro-oncology 85:133-148, 2007
4. Cecic I, Stott B, Korbelik M: Acute phase response-associated systemic neutrophil mobilization in mice bearing tumors treated by photodynamic therapy. International immunopharmacology 6:1259-1266, 2006
5. Colen CB, Shen Y, Ghoddoussi F, Yu P, Francis TB, Koch BJ, et al: Metabolic targeting of lactate efflux by malignant glioma inhibits invasiveness and induces necrosis: an in vivo study. Neoplasia (New York, N.Y.) 13:620-632, 2011
6. Coupienne I, Fettweis Gg, Rubio N, Agostinis P, Piette J: 5-ALA-PDT induces RIP3-dependent necrosis in glioblastoma. Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology 10:1868-1878, 2011
7. Curnow A, Haller JC, Bown SG: Oxygen monitoring during 5-aminolaevulinic acid induced photodynamic therapy in normal rat colon: comparison of continuous and fractionated light regimes. Journal of Photochemistry and Photobiology:58 149-155, 2000
8. Curnow A, McIlroy BW, Postle-Hacon MJ, MacRobert AJ, Bown SG: Light dose fractionation to enhance photodynamic therapy using 5-aminolevulinic acid in the normal rat colon. Photochemistry and photobiology 69:71-76, 1999
9. Dereski MO, Chopp M, Chen Q, Hetzel FW: Normal brain tissue response to photodynamic therapy: histology, vascular permeability and specific gravity. Photochemistry and photobiology 50:653-657, 1989
10. Han S, Li Z, Master LM, Master ZW, Wu A: Exogenous IGFBP-2 promotes proliferation, invasion, and chemoresistance to temozolomide in glioma cells via the integrin β1-ERK pathway. British journal of cancer, 2014
11. Henderson B DT: HOW DOES PHOTODYNAMIC THERAPY WORK? Photochemistry and photobiology 55:145157, 1992
12. Hu LS, Eschbacher JM, Heiserman JE, Dueck AC, Shapiro WR, Liu S, et al: Reevaluating the imaging definition of tumor progression: perfusion MRI quantifies recurrent glioblastoma tumor fraction, pseudoprogression, and radiation necrosis to predict survival. Neuro-oncology 14:919-930, 2012
13. Iacob G, Dinca EB: Current data and strategy in glioblastoma multiforme. Journal of medicine and life 2:386-393, 2009
14. Jiang F, Zhang X, Kalkanis SN, Zhang Z, Yang H, Katakowski M, et al: Combination therapy with antiangiogenic treatment and photodynamic therapy for the nude mouse bearing U87 glioblastoma. Photochemistry and photobiology 84:128-137, 2008
15. Korbelik M: PDT-associated host response and its role in the therapy outcome. Lasers in surgery and medicine 38:500-508, 2006
16. Olzowy B, Hundt CS, Stocker S, Bise K, Reulen HJ, Stummer W: Photoirradiation therapy of experimental malignant glioma with 5-aminolevulinic acid. Journal of neurosurgery 97:970-976, 2002
17. Ostrom QT, Bauchet L, Davis FG, Deltour I, Fisher JL, Langer CE, et al: The epidemiology of glioma in adults: a "state of the science" review. Neuro-oncology 16:896-913, 2014
18. Paxinos G, Watson C, Pennisi M, Topple A: Bregma, lambda and the interaural midpoint in stereotaxic surgery with rats of different sex, strain and weight. Journal of neuroscience methods 13:139-143, 1985
19. Petrecca K, Guiot MC, Panet-Raymond V, Souhami L: Failure pattern following complete resection plus radiotherapy and temozolomide is at the resection margin in patients with glioblastoma. Journal of neuro-oncology 111:19-23, 2013
20. Schuierer G, Reimer P, Allkemper T, Peters PE: [Fast and ultra-fast MRI of the brain]. Radiologe 35:894-901, 1995
21. Stummer W, Beck T, Beyer W, Mehrkens JH, Obermeier A, Etminan N, et al: Long-sustaining response in a patient with non-resectable, distant recurrence of glioblastoma multiforme treated by interstitial photodynamic therapy using 5-ALA: case report. Journal of neurooncology 87:103-109, 2008
22. Tetard MC VM, Lejeune JP, Mordon S, Reyns N: Experimental use of Photodynamic Therapy in high grade gliomas: a review focused on 5-aminolevulinic acid. Photodiagnosis and photodynamic therapy, 2014
23. Tetard MC VM, Leroy HA, Lejeune JP, Mordon S, Reyns N: Light dose fractionation to enhance photodynamic therapy with 5-aminolevulinic acid in human glioma xenografts. Preliminary study., in International Congress on Photodynamic Applications. Dundee, 2014
24. Toussaint M TM, Amouroux M, Bastogne T, Frochot C, Mordon S, Barberi-Heyob M: Optimization of illumination in interstitial photodynamic therapy for high-grade brain tumors, in International Congress on Photodynamic Applications. Dundee, UK, 2014
25. Towner RA, Gillespie DL, Schwager A, Saunders DG, Smith N, Njoku CE, et al: Regression of glioma tumor growth in F98 and U87 rat glioma models by the Nitrone OKN-007. Neurooncology 15:330-340, 2013
26. Tran DK, Jensen RL: Treatment-related brain tumor imaging changes: So-called "pseudoprogression" vs. tumor progression: Review and future research opportunities. Surgical neurology international 4:35, 2013
27. Webber J, Kessel D, Fromm D: Side effects and photosensitization of human tissues after aminolevulinic acid. The Journal of surgical research 68:31-37, 1997
28. Wicks RT, Azadi J, Mangraviti A, Zhang I, Hwang L, Joshi A, et al: Local delivery of cancercell glycolytic inhibitors in high-grade glioma. Neuro-oncology, 2014
29. Wong EC, Buxton RB, Frank LR: Implementation of quantitative perfusion imaging techniques for functional brain mapping using pulsed arterial spin labeling. NMR in biomedicine 10:237-249, 1997
30. Yoshida Y, Dereski MO, Garcia JH, Hetzel FW, Chopp M: Neuronal injury after photoactivation of photofrin II. The American journal of pathology 141:989-997, 1992
31. Zhan Q, Yue W, Hu S: Effect of photodynamic therapy and endostatin on human glioma xenografts in nude mice. Photodiagnosis and photodynamic therapy 8:314-320, 2011
32. Zhang X, Cong D, Shen D, Gao X, Chen L, Hu S: The effect of bumetanide on photodynamic therapy-induced peri-tumor edema of C6 glioma xenografts. Lasers in surgery and medicine 46:422-430, 2014